JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weingartl, H.
Right arrow Articles by Cao, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weingartl, H.
Right arrow Articles by Cao, J.

 Previous Article  |  Next Article 

Journal of Virology, November 2004, p. 12672-12676, Vol. 78, No. 22
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.22.12672-12676.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Immunization with Modified Vaccinia Virus Ankara-Based Recombinant Vaccine against Severe Acute Respiratory Syndrome Is Associated with Enhanced Hepatitis in Ferrets

Hana Weingartl,1,2,{dagger} Markus Czub,2,3,{dagger} Stefanie Czub,1,2 James Neufeld,1 Peter Marszal,1 Jason Gren,1 Greg Smith,1 Shane Jones,3 Roxanne Proulx,3 Yvonne Deschambault,3 Elsie Grudeski,3 Anton Andonov,2,3 Runtao He,2,3 Yan Li,2,3 John Copps,1 Allen Grolla,3 Daryl Dick,3 Jody Berry,1,2 Shelley Ganske,1 Lisa Manning,1 and Jingxin Cao2,3*

National Centre for Foreign Animal Diseases,1 National Microbiology Laboratory, Canadian Science Centre for Human and Animal Health, Winnipeg, Manitoba, Canada R3E 3R2,3 Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada R3T 2N22

Received 29 April 2004/ Accepted 29 July 2004

Severe acute respiratory syndrome (SARS) caused by a newly identified coronavirus (SARS-CoV) is a serious emerging human infectious disease. In this report, we immunized ferrets (Mustela putorius furo) with recombinant modified vaccinia virus Ankara (rMVA) expressing the SARS-CoV spike (S) protein. Immunized ferrets developed a more rapid and vigorous neutralizing antibody response than control animals after challenge with SARS-CoV; however, they also exhibited strong inflammatory responses in liver tissue. Inflammation in control animals exposed to SARS-CoV was relatively mild. Thus, our data suggest that vaccination with rMVA expressing SARS-CoV S protein is associated with enhanced hepatitis.


* Corresponding author. Mailing address: National Microbiology Laboratory, Canadian Science Centre for Human and Animal Health, 1015 Arlington St., Winnipeg, MB, Canada R3E 3R2. Phone: (204) 789-6052. Fax: (204) 789-2082. E-mail: jingxin_cao{at}hc-sc.gc.ca.

{dagger} H.W. and M.C. contributed equally to this work.


Journal of Virology, November 2004, p. 12672-12676, Vol. 78, No. 22
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.22.12672-12676.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2004 by the American Society for Microbiology. All rights reserved.